Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08)
These drugs help the body release insulin when needed and slow down digestion, which can reduce hunger and promote feelings of fullness
Since the mid-2000s, the structure of dipeptidyl peptidase-4 (DPP-4, CD26), an enzyme that decomposes GLP-1, has been discovered
These next-generation drugs go beyond the mechanisms of current GLP-1 medications such as Ozempic, Wegovy, Semaglutide, and Mounjaro , introducing multi-hormone metabolic therapies and even oral alternatives
Neuroprotective Potential: Preclinical and early clinical research suggests GLP-1 may have protective effects on the brain
Pancreatitis, or inflammation of the pancreas, can cause symptoms such as severe abdominal pain, nausea, and vomiting, and can be life-threatening if not treated promptly